| Drug Type Antibody fusion proteins | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism PDGF inhibitors(Platelet-derived growth factor inhibitors), VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Discovery | China  | 30 Jan 2023 | 






